Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sarcoma Oncology Research Center, LLC
Stanford University
National Cancer Institute (NCI)
Cardinal Health 414, LLC
Pfizer
Memorial Sloan Kettering Cancer Center
Albert Einstein College of Medicine
National Cancer Institute (NCI)
Hoffmann-La Roche
Bristol-Myers Squibb
Nektar Therapeutics
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
National Institutes of Health Clinical Center (CC)
Pfizer
Daiichi Sankyo
Celgene
Novartis
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
GE Healthcare
INSYS Therapeutics Inc